Chemoinformaics analysis of 11-Hydroxytetradecanoic acid
Molecular Weight | 244.375 | nRot | 12 |
Heavy Atom Molecular Weight | 216.151 | nRig | 1 |
Exact Molecular Weight | 244.204 | nRing | 0 |
Solubility: LogS | -3.236 | nHRing | 0 |
Solubility: LogP | 3.844 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 44.4562 |
nHD | 2 | BPOL | 28.9578 |
QED | 0.514 |
Synth | 2.388 |
Natural Product Likeliness | 1.08 |
NR-PPAR-gamma | 0.979 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.17 |
Pgp-sub | 0.018 |
HIA | 0.016 |
CACO-2 | -5.091 |
MDCK | 0.0000402 |
BBB | 0.688 |
PPB | 0.941714 |
VDSS | 0.33 |
FU | 0.0365102 |
CYP1A2-inh | 0.055 |
CYP1A2-sub | 0.355 |
CYP2c19-inh | 0.024 |
CYP2c19-sub | 0.37 |
CYP2c9-inh | 0.082 |
CYP2c9-sub | 0.98 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.107 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.022 |
CL | 6.802 |
T12 | 0.809 |
hERG | 0.024 |
Ames | 0.005 |
ROA | 0.007 |
SkinSen | 0.624 |
Carcinogencity | 0.074 |
EI | 0.97 |
Respiratory | 0.198 |
NR-Aromatase | 0.038 |
Antiviral | Yes |
Prediction | 0.798007 |